Comparison of efficacy Dapsone 5% with Erythromycin 2% in treatment of mild papulopustular acne
Phase 3
- Conditions
- Mild papulopustular acne.Acne vulgaris
- Registration Number
- IRCT201607232581N5
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with Papulopustular mild acne; age greater than 12 years old; normal levels of G6PD
Exclusion criteria: patient's decision to exit the study; the risk of severe and moderate conglobata acne or nodulocystic acne; use of topical medications in the past week; taking oral medications in the past four weeks; have allergy to dapsone sulfate; pregnancy or planning to pregnancy or breastfeeding; lesions have been exacerbated enough that the need for systemic therapy; use of isotretinoin in 3 months ago; patients under 12 years of age old; G6PD deficiency
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Acne severity index. Timepoint: zero,second,forth weeks and third month. Method of measurement: Counting.
- Secondary Outcome Measures
Name Time Method umber of papule. Timepoint: zero,second,forth weeks and third month. Method of measurement: count.